Search Results - "ABDULKADYROV, K. M"

The specific features of diagnosis of mixed-phenotype acute leukemia: A combination of B-cell antigen expressions according to the results of flow cytometry and morphological markers of myeloid differentiation in blast cells: A clinical case by Gritsaev, S V, Kostroma, I I, Ryadnova, G M, Tiranova, S A, Chubukina, Zh V, Balashova, V A, Zenina, M N, Martynkevich, I S, Potikhonova, N A, Abdulkadyrov, K M

“…This rare type of acute leukemia, blast cells of which express myeloid and/or lymphoid markers, is mainly diagnosed using flow cytometric findings. The paper…”
Get full text

Heterogeneity of acute myeloid leukemia with the translocation t(8;21)(q22;q22) by Gritsaev, S V, Martynkevich, I S, Ziuzgin, I S, Kariagina, E V, Martynenko, L S, Petrova, E V, Tsybakova, N Iu, Ivanova, M P, Kostroma, I I, Tiranova, S A, Potikhonova, N A, Abdulkadyrov, K M

“…To characterize the clinical and hematological variability of acute myeloid leukemia (AML) with t(8;21) and to identify the signs associated with the…”
Get full text

The specific features of the immunophenotype of blast cells in patients with de novo normal karyotype acute myeloid leukemia and FLT3-ITD mutation by Gritsaev, S V, Martynkevich, I S, Chubukina, Zh V, Petrova, E V, Kostroma, I I, Ivanova, M P, Martynenko, L S, Potikhonova, N A, Bubnova, L N, Abdulkadyrov, K M

“…To study the specific features of de novo acute myeloid leukemia (AML) with FLT3-ITD mutation. The results of examination were analyzed in 101 patients. Bone…”
Get full text

Time course of changes in iron metabolic and oxidative-antioxidative system parameters in patients with acute myeloid leukemia by Gritsaev, S V, Shikhbabaeva, D I, Rybakova, L P, Sergeev, A N, Kapustin, S I, Abdulkadyrov, K M

“…To study an association between iron metabolism, free radical oxidation (FRO), and antioxidative system (AOS) in patients with acute myeloid leukemia (AML)…”
Get full text

Prognostic value of a number of blood laboratory parameters in the use of erythropoiesis-stimulating agents in anemic patients with lymphoproliferative diseases by Romanenko, N A, Bessmel'tsev, S S, Berkos, M V, Rozanova, O E, Abdulkadyrov, K M

“…To clarify the prognostic value of the baseline blood levels of endogenous erythropoietin (EE) and tumor necrosis factor-a (TNF-a) involved in the key…”
Get full text

Cytogenetic profile in patients with primary myelodysplastic syndrome by Gritsaev, S V, Martynkevich, I S, Petrova, E V, Martynenko, L S, Ivanova, M P, Aksenova, V Iu, Tsybakova, N Iu, Potikhonova, N A, Abdulkadyrov, K M

“…To analyze the prevalence of chromosome aberrations presented in the revised International Prognostic Scoring System (R-IPSS) in patients with de novo…”
Get full text

Complex karyotype is a marker of very poor prognosis in over 70-year-old patients with acute myeloid leukemia and extended types of myelodysplastic syndrome and high comorbidity index by Gritsaev, S V, Martynkevich, I S, Abdulkadyrov, K M, Ivanova, M P, Petrova, E V, Zapreeva, I M, Tiranova, S A, Potikhonova, N A

“…To identify a category of persons with very low overall survival (OS) rates, whose intensive chemotherapy is unreasonable, amongst the patients with acute…”
Get full text

FLT3 and NPM1 gene mutations in patients with acute myeloid leukemias and the impact of FLT3-ITD mutations on the survival of patients with a normal karyotype by Martynkevich, I S, Gritsaev, S V, Moskalenko, M V, Ivanova, M P, Aksenova, V Iu, Tiranova, S A, Abdulkadyrov, K M

“…To estimate the extent of FLT3 and NPM1 gene mutations and the impact of mutations of FLT3-ITD on the survival of patients with acute myeloid leukemias (AML)…”
Get full text

Dasatinib: ten years of clinical practice worldwide by Abdulkadyrov, K. M., Shuvaev, V. A., Martynkevich, I. S.

“…The article contains results of meta-analysis of experience in use of second-generation tyrosine kinase inhibitors – dasatinib. The results of clinical trials…”
Get full text

All we know about polycythemia vera: literature review and own experience by Abdulkadyrov, K. M., Shuvaev, V. A., Martynkevich, I. S.

“…The literature review and own long-term polycythemia vera diagnosis and treatment experience are presented in this article. The results of newest advances in…”
Get full text

Primary myelofibrosis: own experience and news from diagnostic and treatment by Abdulkadyrov, K. M., Shuvaev, V. A., Martynkevich, I. S.

“…The newest advances in primary myelofibrosis (PMF) pathogenesis study, diagnostic and treatment approaches are presented in this article. The JAK-STAT signal…”
Get full text

Combination therapy with ruxolitinib plus low-dose cytarabine or mercaptopurine in patients with blast-phase myelofibrosis by Fominykh, M. S., Shuvaev, V. A., Martynkevich, I. S., Polushkina, L. B., Udal’eva, V. Yu, Abdulkadyrov, K. M.

“…Patients with myelofibrosis in blast-phase commonly have a median overall survival of only 3–6 months. Given the older median age of onset and heavy…”
Get full text

THROMBOTIC AND BLEEDING RISK FACTORS IN ESSENTIAL THROMBOCYTHEMIA by Zhernyakova, A. A., Martynkevich, I. S., Shuvaev, V. A., Polushkina, L. B., Fominykh, M. S., Udal’eva, V. Yu, Zotova, I. I., Shiсhbabaeva, D. I., Voloshin, S. V., Бессмельцев, S. S., Chechetkin, A. V., Abdulkadyrov, K. M.

“…Background. Thrombosis and hemorrhage are the main category of complications, that affects the overall survival (OS), quality of life and therapy option choice…”
Get full text

The multicenter experience with bendamustine in the treatment of relapsed and refractory multiple myeloma by Voloshin, S. V., Bessmeltsev, S. S., Zagoskina, T. P., Medvedeva, N. V., Kaplanov, K. D., Karyagina, E. V., Garifullin, A. D., Kuvshinov, A. Yu, Stelmashenko, L. V., Abdulkadyrov, K. M.

“…Relapsed and refractory (R/R) multiple myeloma (MM) constitutes a specific and unmet medical need. Median survival ranges from as little as 6 to 9 months, and…”
Get full text

First research of use Vero-Fludarabine in chronic lymphocytic leukemia and non-hodgkins lymphoma by S. S. Bessmeltsev, K. M. Abdulkadyrov

“…The aim of the investigation was to estimate Vero-Fludarabine in chronic lymphocytic leukemia and non-Hodgkin’s lymphoma patients. We report the activity of…”
Get full text

Age-specific features of acute myeloid leukemia karyotype by Sergey Vasil'evich Gritsaev, Irina Stepanovna Martynkevich, Lyudmila Sergeevna Martynenko, Marina Petrovna Ivanova, Vasilisa Yur'evna Aksenova, Mikhail Viktorovich Moskalenko, Irina Mikhaylovna Zapreeva, Kudrat Mugutdinovich Abdulkadyrov, S V Gritsaev, I S Martynkevich, L S Martynenko, M P Ivanova, V Yu Aksenova, M V Moskalenko, I M Zapreeva, K M Abdulkadyrov, Sof'ya Aleksandrovna Tiranova

“…Aim. To study distribution of some karyotype variants among patients of different age with acute myeloid leukemia (AML). Material and methods. Distribution of…”
Get full text

Investigation of FLT3-ITD and NPM1 mutations in patients with myelodysplastic syndrome and mixed myeloid diseases by Gritsaev, S V, Martynkevich, I S, Ivanova, M P, Moskalenko, M V, Aksenova, V Iu, Tiranova, S A, Abdulkadyrov, K M

“…Two FLT3-ITD mutations, one FLT3-TKD) and five NPM1 mutations were detected in 7 patients with de novo myelodysplastic syndrome (MDS) out of 44 cases of MDS…”
Get more information

HLA-DR4-Ala74 beta is associated with risk and poor outcome of severe aplastic anemia by Kapustin, S I, Popova, T I, Lyshchov, A A, Imyanitov, E N, Blinov, M N, Abdulkadyrov, K M

“…Severe aplastic anemia (SAA) is a heterogeneous hematological disorder with a high mortality. Genetic predisposition has been shown to play a role in a…”
Get full text

Influence of TNF-alpha on the efficacy of anemia correction in patients with lymphoproliferative disorders by N. A. Romanenko, S. S. Bessmeltsev, O. E. Rozanova, N. S. Karpova, K. M. Abdulkadyrov

“…In this article mechanisms of anaemia development in patients with lymphatic tissue malignant diseases are presented. Therapy efficacy of…”
Get full text

Clinical significance of lymphocyte subpopulations and cytokine-producing activity of blood cells in patients with primary myelodysplastic syndrome by Gritsaev, S V, Rozanova, O E, Abdulkadyrov, K M, Bubnova, L N, Tiranova, S A

“…Lymphocyte subpopulation composition and spontaneous production of tumor necrosis factor-alpha (TNF-alpha) by blood cells were studied in 22 and 15 patients…”
Get more information